These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9157332)

  • 21. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology.
    Tofighy A; Abbott A; Centonze D; Cooper AJ; Noor E; Pearce SM; Puntis M; Stanford IM; Wigmore MA; Lacey MG
    Neuroscience; 2003; 116(1):157-66. PubMed ID: 12535949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
    Waszczak BL; Martin LP; Finlay HE; Zahr N; Stellar JR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats.
    Blandini F; Garcia-Osuna M; Greenamyre JT
    Eur J Neurosci; 1997 Jul; 9(7):1407-13. PubMed ID: 9240398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT
    Lagière M; Bosc M; Whitestone S; Benazzouz A; Chagraoui A; Millan MJ; De Deurwaerdère P
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
    Frau L; Morelli M; Simola N
    Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
    Gong W; Neill DB; Lynn M; Justice JB
    Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
    Singh J; Desiraju T; Raju TR
    Indian J Physiol Pharmacol; 1996 Jan; 40(1):15-22. PubMed ID: 8864766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D-1 receptor-mediated inhibition of nucleus accumbens neurons from the ventral tegmental area.
    Sasa M; Hara M; Takaori S
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):119-28. PubMed ID: 1826178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellularly recorded response of rat striatal neurons in vitro to fenoldopam and SKF 38393 following lesions of midbrain dopamine cells.
    Twery MJ; Thompson LA; Walters JR
    Synapse; 1994 Sep; 18(1):67-78. PubMed ID: 7825125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE; Holtzman SG
    Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists.
    Napier TC
    Synapse; 1992 Feb; 10(2):110-9. PubMed ID: 1350111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction.
    Simola N; Di Chiara G; Daniels WM; Schallert T; Morelli M
    Neuroscience; 2009 Feb; 158(4):1625-31. PubMed ID: 19063947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo characterization of two cell types in the rat globus pallidus which have opposite responses to dopamine receptor stimulation: comparison of electrophysiological properties and responses to apomorphine, dizocilpine, and ketamine anesthesia.
    Kelland MD; Soltis RP; Anderson LA; Bergstrom DA; Walters JR
    Synapse; 1995 Aug; 20(4):338-50. PubMed ID: 7482293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF
    Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.